In this report, we provide the first evidence that TREM1 expression in breast tumors has negative prognostic and therapy-predictive implications for breast cancer patients, and that TREM1 expression is mediated predominantly by breast tumor-infiltrating myeloid cells that may constitute a cell population that antagonizes anti-tumor immunity. Here, TREM1 is linked to breast cancer.